Table 3.
Advantages and disadvantages of phospholipid based nanocarrier systems.
| Vesicular nanocarrier | Advantages | Disadvantages | References |
|---|---|---|---|
| Liposomes | Improved drug stability | Drug leakage | [22], [28], [29], [30] |
| Available in various size range | Scale-up difficulty | ||
| Reduced drug toxicity | Dose dumping | ||
| Prolonged drug release | Sterilization problems | ||
| Ethosomes | High skin permeation compared to liposomes | Chances of coalescence | [41], [42] |
| Non-toxic raw materials | Poor yield problems | ||
| Smaller size compared to liposomes | Less stability | ||
| Transfersomes | Higher penetration compared to liposomes and ethosomes | Expensive | [53], [54] |
| Systemic and topical delivery | Difficult manufacturing | ||
| Transethosomes | Higher penetration compared to ethosomes | Scale-up problems | [58] |
| Higher stability compared to ethosomes | Expensive |